Newpath Management
Newpath Partners is a life science venture firm dedicated to excellent science and to forming partnerships.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Newpath Management Information
Geographic Data
Address: 800 Boylston Street
City: Boston
State: MA
Zip: 02199
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$711M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Newpath Partners, LP is a life science venture firm dedicated to excellent science and to forming partnerships based on trust and a shared vision.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2023 | Myeloid Therapeutics | Series A | 0 |
| 6/2021 | Kojin Therapeutics | Series A | 60M |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 10/2021 | Neumora Therapeutics | Series A | 0 |
| 7/2021 | Prime Medicine | Series B | 200M |
| 12/2020 | Exo Therapeutics | Series A | 25M |
| 3/2023 | Chroma Medicine | Series B | 0 |
| 1/2021 | Myeloid Therapeutics | Series A | 50M |
| 10/2019 | Prime Medicine | Series A | 115M |
| 9/2021 | YourBio Health | Venture Round | 21M |
| 9/2022 | Orbital Therapeutics | Seed Round | - |
| 10/2022 | Neumora Therapeutics | Series B | 0 |
| 4/2023 | Orbital Therapeutics | Series A | 0 |
| 5/2023 | Myeloid Therapeutics | Series B | 0 |
| 10/2021 | Neumora Therapeutics | Series A | 0 |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 9/2021 | YourBio Health | Venture Round | 0 |
| 7/2021 | Prime Medicine | Series B | 0 |
| 6/2021 | Kojin Therapeutics | Series A | 0 |
| 1/2021 | Myeloid Therapeutics | Series A | 0 |
| 12/2020 | Exo Therapeutics | Series A | 0 |
| 10/2019 | Prime Medicine | Series A | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
